486 related articles for article (PubMed ID: 34775722)
1. [The efficacy and safety of ticagrelor versus clopidogrel in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention].
Na K; Li MY; Qiu MH; Li J; Liu R; Li Y; Han YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Nov; 49(11):1117-1123. PubMed ID: 34775722
[No Abstract] [Full Text] [Related]
2. Net clinical benefit of clopidogrel versus ticagrelor in elderly patients carrying CYP2C19 loss-of-function variants with acute coronary syndrome after percutaneous coronary intervention.
Zhang D; Li P; Qiu M; Liang Z; He J; Li Y; Han Y
Atherosclerosis; 2024 Mar; 390():117395. PubMed ID: 38114408
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of switching from ticagrelor to clopidogrel during the early and late phase in acute coronary syndrome patients after percutaneous coronary intervention.
Wang C; Zheng W; Shaqdan A; Wang C; Qin X; Zhao X; Wang X; Yuan L; Nie S; Liu R
Platelets; 2020; 31(3):337-343. PubMed ID: 31043110
[TBL] [Abstract][Full Text] [Related]
4. Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Turgeon RD; Koshman SL; Youngson E; Har B; Wilton SB; James MT; Graham MM
JAMA Intern Med; 2020 Mar; 180(3):420-428. PubMed ID: 31930361
[TBL] [Abstract][Full Text] [Related]
5. Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries.
Bianco M; Careggio A; Biolè CA; Quadri G; Quiros A; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solè A; Liebetrau C; Manzano-Fernàndez S; Boccuzzi G; Henriques JPS; Spirito A; Templin C; Wilton SB; Velicki L; Correia L; Rognoni A; Ugo F; Nunez-Gil I; Fujii T; Durante A; Song X; Kawaji T; Alexopoulos D; Huczek Z; Gonzàlez Juanatey JR; Nie SP; Kawashiri MA; Morbiducci U; Dominguez-Rodriguez A; Destefanis P; Luciano A; De Ferrari GM; Varbella F; Montagna L; D'Ascenzo F; Cerrato E
Cardiovasc Drugs Ther; 2021 Dec; 35(6):1171-1182. PubMed ID: 34224052
[TBL] [Abstract][Full Text] [Related]
6. P2Y12 Inhibitors in Acute Coronary Syndromes: A Real-World, Community-Based Comparison of Ischemic and Bleeding Outcomes.
Sachdeva A; Mutyala R; Mantri N; Zhu S; McNulty E; Solomon M
J Interv Cardiol; 2023; 2023():1147352. PubMed ID: 37251366
[TBL] [Abstract][Full Text] [Related]
7. Impact of Ticagrelor vs. Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention After Risk Stratification With the CHA
Na K; Qiu M; Ma S; Li Y; Li J; Liu R; Zhang J; Han Y
Front Cardiovasc Med; 2022; 9():808571. PubMed ID: 35445091
[TBL] [Abstract][Full Text] [Related]
8. The contribution of genotype-guided selection of P2Y
Wu Y; Yu D; Zhang L; Wu Y; Shu B; Ma L; Shi T
Eur J Clin Pharmacol; 2023 Sep; 79(9):1249-1259. PubMed ID: 37449992
[TBL] [Abstract][Full Text] [Related]
9. Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention.
Zheng W; Li Y; Tian J; Li L; Xie L; Mao Q; Tong W; Zhou D; Azzalini L; Zhao X
Biomed Res Int; 2019; 2019():3170957. PubMed ID: 31016189
[TBL] [Abstract][Full Text] [Related]
10. Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
You SC; Rho Y; Bikdeli B; Kim J; Siapos A; Weaver J; Londhe A; Cho J; Park J; Schuemie M; Suchard MA; Madigan D; Hripcsak G; Gupta A; Reich CG; Ryan PB; Park RW; Krumholz HM
JAMA; 2020 Oct; 324(16):1640-1650. PubMed ID: 33107944
[TBL] [Abstract][Full Text] [Related]
11. Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention.
Li Y; Li J; Qiu M; Ma S; Na K; Li X; Qi Z; Chen S; Li Y; Han Y
Catheter Cardiovasc Interv; 2022 May; 99 Suppl 1():1395-1402. PubMed ID: 35032148
[TBL] [Abstract][Full Text] [Related]
12. Contemporary Use of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A GRACE Risk Score Stratification-Based Analysis in a Large-Scale, Real-World Study From China.
Qiu M; Na K; Qi Z; Zhou H; Li P; Xu K; Wang B; Liu H; Li J; Li Y; Han Y
Mayo Clin Proc; 2023 Jul; 98(7):1021-1032. PubMed ID: 37419570
[TBL] [Abstract][Full Text] [Related]
13. A Comparative Study on Ticagrelor and Clopidogrel in Patients With Acute Coronary Syndrome Treated With Primary Percutaneous Coronary Intervention.
Wu H; Jia S
J Clin Pharmacol; 2023 Jul; 63(7):776-783. PubMed ID: 37017131
[TBL] [Abstract][Full Text] [Related]
14. Ticagrelor versus Clopidogrel in Patients with Severe Renal Insufficiency Undergoing PCI for Acute Coronary Syndrome.
Chen Y; Tu S; Chen Z; Xia J; Chen B; Chen J; Liang J; Liu X; Tang L
J Interv Cardiol; 2022; 2022():6476777. PubMed ID: 35966043
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Cohort Study.
Meng S; Guo L; Ye Z; Wang J; Ding H; Wu S; Huang R
Clin Interv Aging; 2022; 17():331-341. PubMed ID: 35400997
[TBL] [Abstract][Full Text] [Related]
16. Ticagrelor as Compared to Clopidogrel Following Percutaneous Coronary Intervention for Acute Coronary Syndrome.
Wiens EJ; Leon SJ; Whitlock R; Tangri N; Shah AH
Am J Cardiol; 2023 Jul; 198():26-32. PubMed ID: 37196530
[TBL] [Abstract][Full Text] [Related]
17. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial.
Pereira NL; Farkouh ME; So D; Lennon R; Geller N; Mathew V; Bell M; Bae JH; Jeong MH; Chavez I; Gordon P; Abbott JD; Cagin C; Baudhuin L; Fu YP; Goodman SG; Hasan A; Iturriaga E; Lerman A; Sidhu M; Tanguay JF; Wang L; Weinshilboum R; Welsh R; Rosenberg Y; Bailey K; Rihal C
JAMA; 2020 Aug; 324(8):761-771. PubMed ID: 32840598
[TBL] [Abstract][Full Text] [Related]
18. Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Wang HY; Li Y; Xu XM; Li J; Han YL
Chin Med J (Engl); 2018 Sep; 131(17):2017-2024. PubMed ID: 30127210
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Net Clinical Benefit Between Clopidogrel and Ticagrelor Following Percutaneous Coronary Intervention in Patients in China With Acute Coronary Syndrome.
Li D; Sun Y; Ye X; Li L; Chen Y; Wang D
Adv Ther; 2022 Jan; 39(1):754-766. PubMed ID: 34904209
[TBL] [Abstract][Full Text] [Related]
20. Clopidogrel versus ticagrelor in East Asian patients aged 75 years or older with acute coronary syndrome: observations from the GF-APT registry.
Xi Z; Qiu Z; Li J; Qiu H; Guo T; Wang Y; Zheng J; Gao Y; Gao R
Platelets; 2022 Nov; 33(8):1270-1278. PubMed ID: 36050819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
